Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants

  • Acharya A
  • Pandey K
  • Thurman M
  • et al.
30Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The ongoing coronavirus infectious disease 2019 (COVID-19) pandemic is caused by a novel coronavirus named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). More than 207 million people have been infected globally, and 4.3 million have died due to this viral outbreak.

Cite

CITATION STYLE

APA

Acharya, A., Pandey, K., Thurman, M., Klug, E., Trivedi, J., Sharma, K., … Byrareddy, S. N. (2021). Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants. Journal of Virology, 95(24). https://doi.org/10.1128/jvi.01437-21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free